A Cutting-Edge Start-up Harnesses Artificial Intelligence to Create a Psychedelic without the High!
“A Startup Used AI to Make a Psychedelic Without the Trip”
“‘These three molecules have a very similar structure to classic psychedelics,’ says Shlomi Raz, the founder of Eleusis, a psychedelic-inspired pharmaceutical company. ‘They’re just missing the part that causes the trip.'”
Well, isn’t that a bit like serving a chocolate cake without the chocolate? That’s the approach that Eleusis, the pharmaceutical company, is experimenting with. They’re toying around with psychedelic drugs, just minus the… well, psychedelic part. Interesting, isn’t it?
In essence, they’re leveraging the power of artificial intelligence to detour the trip-inducing part of psychedelics. It’s like they’ve created a digital traffic controller, rerouting the trip component of these psychedelics so you’re left experiencing a ‘chemical cul-de-sac’, one that doesn’t involve the visual equivalent of a unicorn parading down the street.
Keep in mind, this isn’t for your random Friday night kicks. No, this is with the noble aim of creating new treatments for chronic diseases such as inflammation and mental health disorders. Stick with them, they’re going somewhere with this.
So yes, the research is happening – it’s real and moving rapidly. The team at Eleusis are effectively the digital chemists of our era. They’re utilizing AI to predict the psychedelic potency of the drugs they’re dealing with. Pretty neat, huh?
At the core of their strategy, Eleusis is exploring with deactivated psychedelics. Picture this: It’s like building a fully-functional race car but tweaking it in such a way that it can’t go above the speed limit. That’s the non-trippy part.
Wait, what about the argument that the psychedelic experience is essential to inducing therapeutic benefits? Well, Eleusis is politely giving the silent treatment to that aspect for now. Their version of life does not include chasing fantastical rainbows or engaging in a telepathic conversation with a plant. Telepathic plant conversations may be your thing, but not here.
On a serious note, there is potential in these non-hallucinogenic psychedelics for treatment of conditions like cardiovascular disease and diabetes. And who knows? It might not be too far-fetched to foresee a world where depression is treated with a pill, sans the trip, derived from what was once considered counter-culture psychedelia. There’s some food for thought.
Is there criticism? Of course, the world is full of opinions. But Eleusis is moving forward anyway. After all, in the face of progress, pondering is good but acting is better.
To wrap it up, is it really a psychedelic if it doesn’t make you trip? Well, according to Eleusis and their AI-induced chemist, absolutely yes. So, while the rest of the world is up there, dancing with the stars, they’ll be grounded, trying to turn deactivated psychedelics into beneficial pharmaceuticals. Yes, without the trip. Now, aren’t you glad you didn’t have to plan ahead and get that trippy tie-dye t-shirt, after all?